Amedeo Smart

Free Medical Literature Service

 

Amedeo

Biliary Tract Diseases
  Free Subscription

Articles published in
Clin Nucl Med
    September 2025
  1. SUN Y, Jiang J, Meng Q, Wang W, et al
    68Ga-FAPI-04: A Powerful Tool for Detecting Subcentimeter Metastases of Intrahepatic Cholangiocarcinoma.
    Clin Nucl Med. 2025 Sep 18. doi: 10.1097/RLU.0000000000006114.
    >> Share

    August 2025
  2. XIE Y, Lin X, Chen Y
    68Ga-FAPI-04 Versus 18F-FDG PET/CT in a Case of Xanthogranulomatous Cholecystitis.
    Clin Nucl Med. 2025 Aug 18. doi: 10.1097/RLU.0000000000005984.
    >> Share

    July 2025
  3. MAHDI RA, Raja J, Singh H, Mittal BR, et al
    Pembrolizumab-Induced Acalculous Cholecystitis Mimicking Gallbladder Carcinoma on 18F-FDG PET/CT.
    Clin Nucl Med. 2025 Jul 4. doi: 10.1097/RLU.0000000000005905.
    >> Share

    June 2025
  4. SARASWAT D, Malik P, Kumar S, Sethi A, et al
    Lemmel Syndrome Detected on 99mTc-Mebrofenin Hepatobiliary Scintigraphy.
    Clin Nucl Med. 2025 Jun 17. doi: 10.1097/RLU.0000000000005736.
    >> Share

  5. WANG G, Han N, Wang C, Si Z, et al
    Unusual I-131 Accumulation in the Gallbladder and Intrahepatic Cholangiocarcinoma in a Patient With Papillary Thyroid Cancer.
    Clin Nucl Med. 2025 Jun 9. doi: 10.1097/RLU.0000000000006018.
    >> Share

  6. AKSAKAL M, Liu Y, Chen DL, King G, et al
    Gallbladder Neuroendocrine Tumor and 177Lu DOTATATE: High Somatostatin Receptor Expression Without Clinical Response.
    Clin Nucl Med. 2025 Jun 4. doi: 10.1097/RLU.0000000000006001.
    >> Share

    May 2025
  7. LIU Y, Wang K, Pu J, Ding H, et al
    Pitfall in 68Ga-PSMA PET/CT Interpretation: 68Ga-PSMA Excreted Through the Biliary System.
    Clin Nucl Med. 2025 May 20. doi: 10.1097/RLU.0000000000005718.
    >> Share

  8. NGUYEN NC, Luo J, Arefan D, Vasireddi AK, et al
    Artificial Intelligence in Sincalide-Stimulated Cholescintigraphy: A Pilot Study.
    Clin Nucl Med. 2025 May 13. doi: 10.1097/RLU.0000000000005967.
    >> Share

  9. RAEISI N, Saber Tanha A, Ghahraman M, Aryana K, et al
    Comparable Diagnostic Value of 99mTc-FAPI-46 SPECT/CT and 18F-FDG PET/CT in Cholangiocarcinoma: A Case Report.
    Clin Nucl Med. 2025 May 9. doi: 10.1097/RLU.0000000000005877.
    >> Share

    April 2025
  10. HOU G, Cheng X, Jiang Y, Yang Y, et al
    Comparison of Al18F-NOTA-FAPI-74 and 18F-FDG PET/CT in the Evaluation and Staging of Hepatobiliary Malignancies: A Single-center Prospective Study.
    Clin Nucl Med. 2025 Apr 24. doi: 10.1097/RLU.0000000000005889.
    >> Share

    March 2025
  11. LIANG H, Gao M, Zhao G, Wei L, et al
    Mixed Adenoneuroendocrine Carcinoma of the Common Bile Duct With Solitary Lymph Node Metastasis Revealed on 18F-FDG PET/CT.
    Clin Nucl Med. 2025 Mar 10. doi: 10.1097/RLU.0000000000005776.
    >> Share

  12. OZTURK AE, Akgun E, Alcin G, Gulturk I, et al
    18F-FDG PET/CT Findings Mimicking Gallbladder Metastasis From a Rectal Adenocarcinoma: Rare Synchronous Gallbladder and Rectal Cancer.
    Clin Nucl Med. 2025 Mar 3. doi: 10.1097/RLU.0000000000005812.
    >> Share

    December 2024
  13. XU C, Ren P, Zhao G, Wei L, et al
    Solitary Scapula Metastasis From Intrahepatic Cholangiocarcinoma Detected by PET/CT.
    Clin Nucl Med. 2024 Dec 3. doi: 10.1097/RLU.0000000000005619.
    >> Share

  14. SAHIN OF, Alcin G, Ergul N, Cermik TF, et al
    Physiological Gallbladder Accumulation on 68 Ga-FAPI-46 PET/CT.
    Clin Nucl Med. 2024;49:e685-e686.
    >> Share

    November 2024
  15. MAJEED AK, Datta D, Aggarwal D, Panda B, et al
    Atypical Presentation of Gall Bladder Adenocarcinoma as Paraneoplastic Myeloneuropathy.
    Clin Nucl Med. 2024;49:e585-e586.
    >> Share

    October 2024
  16. IKEJIRI T, Yoh T, Kasai Y, Nagai K, et al
    Hepatic Recurrence of Neuroendocrine Tumor Component in Gallbladder Cancer.
    Clin Nucl Med. 2024 Oct 21. doi: 10.1097/RLU.0000000000005539.
    >> Share

  17. QI N, Ding J, Wang H, Zhao J, et al
    Negative 18F-FDG and Positive 68Ga-FAPI-04 Findings in a Patient With Acute Exacerbation of Chronic Cholecystitis.
    Clin Nucl Med. 2024 Oct 14. doi: 10.1097/RLU.0000000000005504.
    >> Share

    April 2024
  18. KOYASU S, Sugimoto A, Matsubara J, Muto M, et al
    SMARCA4-Deficient Poorly Differentiated Adenocarcinoma of the Gallbladder.
    Clin Nucl Med. 2024 Apr 8. doi: 10.1097/RLU.0000000000005217.
    >> Share

  19. LI H, Song L, Zhao M, Zhang W, et al
    Increased Prostate-Specific Membrane Antigen Uptake in a Gallbladder Stone.
    Clin Nucl Med. 2024;49:344-345.
    >> Share

    March 2024
  20. QI N, Chen X, Zhou Z, Yuan Z, et al
    Positive 18F-FDG and Negative 68Ga-FAPI-04 Findings in a Patient With Gallbladder Adenocarcinoma.
    Clin Nucl Med. 2024 Mar 25. doi: 10.1097/RLU.0000000000005182.
    >> Share

  21. ZHANG Z, Cheng C, Jiang H, Pan G, et al
    68Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma: Comparison With 18F-FDG PET/CT and Abdominal 68Ga-FAPI-04 PET/MR.
    Clin Nucl Med. 2024 Mar 7. doi: 10.1097/RLU.0000000000005112.
    >> Share

  22. LIANG J, Zhang J, Song J, Zhang R, et al
    Intense 18F-FAPI Uptake in Small Recurrent Lesions of Combined Hepatocellular-Cholangiocarcinoma Negative on 18F-FDG PET/CT.
    Clin Nucl Med. 2024 Mar 7. doi: 10.1097/RLU.0000000000005148.
    >> Share

    January 2024
  23. CUI Y, Liu Y, Du B, Li Y, et al
    Gallbladder's Adenocarcinoma With Enteroblastic Differentiation Revealed by 18F-FDG PET/CT.
    Clin Nucl Med. 2024 Jan 16. doi: 10.1097/RLU.0000000000005055.
    >> Share

  24. ZHOU J, Zhao Y
    Rare Findings of Gallbladder Metastasis From Cutaneous Melanoma on 18F-FDG PET/CT Imaging.
    Clin Nucl Med. 2024 Jan 5. doi: 10.1097/RLU.0000000000005035.
    >> Share

  25. SUN Y, Cai X, Wang Z, Sun Y, et al
    Elevated 18 F-AIF-FAPI-04 Uptake in Hepatic Hemangioma.
    Clin Nucl Med. 2024;49:e25-e27.
    >> Share

    November 2023
  26. BEHNAM-MANESH H, Doroudinia A, Bayat M, Bakhshayesh Karam M, et al
    FAPI Uptake in Gallbladder Is It Normal Biodistribution?
    Clin Nucl Med. 2023 Nov 17. doi: 10.1097/RLU.0000000000004955.
    >> Share

    September 2023
  27. AL-IBRAHEEM A, Abdlkadir AS, Alalawi H, Badarneh M, et al
    68GA-FAPI PET/CT Imaging: Unveiling the Hidden Pitfalls.
    Clin Nucl Med. 2023 Sep 21. doi: 10.1097/RLU.0000000000004802.
    >> Share

  28. CHEN L, Sun R, Liu L, Hua J, et al
    Increased 68Ga-FAPI Activity in Primary Small Cell Neuroendocrine Carcinoma of the Gallbladder.
    Clin Nucl Med. 2023 Sep 19. doi: 10.1097/RLU.0000000000004855.
    >> Share

    July 2023
  29. CHAURASIYA K, Kireeva E, Yadgarov M, Akhaladze D, et al
    Role of Preoperative Hepatobiliary Scintigraphy in Children Requiring Liver Resection.
    Clin Nucl Med. 2023;48:581-585.
    >> Share

    May 2023
  30. MESSERSCHMIDT K, Witt R, Krischer L, Sabri O, et al
    Pulmonary Embolism Detected by Bone Scintigraphy in a Patient With Intrahepatic Cholangiocarcinoma.
    Clin Nucl Med. 2023 May 11. doi: 10.1097/RLU.0000000000004680.
    >> Share

    April 2023
  31. AL-IBRAHEEM A, Al-Qasem S, El Khaldi M, Amarin R, et al
    68Ga-FAPI PET/CT Provides a Clear Picture of a Klatskin Tumor That 18F-FDG PET/CT Missed.
    Clin Nucl Med. 2023 Apr 17. doi: 10.1097/RLU.0000000000004652.
    >> Share

  32. RAJARAMAN V, Meenakshi LA, Selvaraj AJ, Pottakkat B, et al
    Role of 68Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies: A Prospective Pilot Study.
    Clin Nucl Med. 2023 Apr 5. doi: 10.1097/RLU.0000000000004641.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016